Chapter 34. To Market, To Market - 1995

This publication has 75 references indexed in Scilit:

• Protection of Normal Tissue from the Cytotoxic Effects of Chemotherapy and Radiation by Amifostine: Clinical Experiences
  European Journal Of Cancer, 1995
• Preclinical pharmacology of docetaxel
  European Journal Of Cancer, 1995
• Anti-tumour effect of aromatase inhibitor, CGS16949A, on human breast cancer cells
  European Journal of Pharmacology: Molecular Pharmacology, 1995
• Clinical activity of leukotriene inhibitors
  International Journal of Immunopharmacology, 1995
• Myocardial infarct artery patency and reocclusion rates after treatment with duteplase at the dose used in the International Study of Infarct Survival-3
  The American Journal of Cardiology, 1993
• Thrombolytic Therapy for Acute Myocardial Infarction
  Drugs, 1992
• In Vitro and ex Vivo Ca-Antagonistic Effect of 2-Methoxyethyl(E)-3-phenyl-2-propen-1-yl(.+-.)-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate (FRC-8653), a New Dihydropyridine Derivative.
  Journal of Pharmacobio-Dynamics, 1992
• Comparative Studies of the Systemic Hemodynamics and Myocardial Oxygen Consumption of FRC 8653, a New Ca++ Channel Blocker, and Nifedipine in Anesthetized Dogs.
  Japanese Heart Journal, 1992
• Design, Properties, and Effective Use of the Oral Chelator L1 and Other
  Annals of the New York Academy of Sciences, 1990
• Protective effect of rimexolone on cartilage damage in arthritic mice: A comparative study with triamcinolone hexacetonide
  Inflammation Research, 1990